dienogest has been researched along with Atypical Endometrial Hyperplasia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Abdeldayem, HM; Girbash, EF; Radwan, AM; Sherif, HE | 1 |
Acmaz, G; Akkaya, H; Cagli, F; Karakilic, EU; Madendag, I; Madendag, Y; Uysal, G | 1 |
Cheung, CW; Fung, WY; Liang, B; Wang, CC; Wong, SW; Wu, L; Xu, H | 1 |
Gräser, T; Koytchev, R; Müller, A; Oettel, M | 1 |
3 trial(s) available for dienogest and Atypical Endometrial Hyperplasia
Article | Year |
---|---|
Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia.
Topics: Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Male; Nandrolone; Norethindrone; Norethindrone Acetate | 2023 |
The Efficacy of Dienogest in the Treatment of Simple Endometrial Hyperplasia without Atypia.
Topics: Adult; Endometrial Hyperplasia; Female; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Premenopause; Progesterone; Progestins; Prospective Studies | 2018 |
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
Topics: Biopsy; Breast Diseases; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Nandrolone; Norethindrone; Postmenopause; Prospective Studies; Therapeutic Equivalency; Treatment Outcome; Uterine Hemorrhage | 2000 |
1 other study(ies) available for dienogest and Atypical Endometrial Hyperplasia
Article | Year |
---|---|
Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
Topics: Animals; Apoptosis; Atrophy; Cell Proliferation; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Endometrium; Female; Mice; Mice, Inbred C57BL; Nandrolone; Norpregnadienes; Progestins; Receptors, Progesterone; Recurrence | 2018 |